The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
PVT1 dependence in cancer with MYC copy-number increase
Open accessAbstract
‘Gain’ of supernumerary copies of the 8q24.21 chromosomal region has been shown to be common in many human cancers and is associated with poor prognosis. The well-characterized myelocytomatosis (MYC) oncogene resides in the 8q24.21 region and is consistently co-gained with an adjacent ‘gene desert’ of approximately 2 megabases that contains the long non-coding RNA gene PVT1, the CCDC26 gene candidate and the GSDMC gene. Whether low copy-number gain of one or more of these genes drives neoplasia is not known. Here we use chromosome engineering in mice to show that a single extra copy of either the Myc gene or the region encompassing Pvt1, Ccdc26 and Gsdmc fails to advance cancer measurably, whereas a single supernumerary segment encompassing all four genes successfully promotes cancer. Gain of PVT1 long non-coding RNA expression was required for high MYC protein levels in 8q24-amplified human cancer cells. PVT1 RNA and MYC protein expression correlated in primary human tumours, and copy number of PVT1 was co-increased in more than 98% of MYC-copy-increase cancers. Ablation of PVT1 from MYC-driven colon cancer line HCT116 diminished its tumorigenic potency. As MYC protein has been refractory to small-molecule inhibition, the dependence of high MYC protein levels on PVT1 long non-coding RNA provides a much needed therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Three-dimensional culture models of normal and malignant breast epithelial cells
Lee, G. Y., Kenny, P. A., Lee, E. H., & Bissell, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1015 · Cited by 1,336
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Kenny, P. A., Lee, G. Y., Myers, C. A., Neve, R. M., Semeiks, J. R., Spellman, P. T., Lorenz, K., Lee, E. H., Barcellos‐Hoff, M. H., PETERSEN, O. W., et al. (2008) · eScholarship (California Digital Library) · Cited by 1,039
Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1110 · Cited by 791
Keene, J. D., Komisarow, J. M., & Friedersdorf, M. B. (2006) · Nature Protocols · doi:10.1038/nprot.2006.47 · Cited by 616
X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA
Nair, S. K., & Burley, S. K. (2003) · Cell · doi:10.1016/s0092-8674(02)01284-9 · Cited by 551
Chromosome engineering in mice
Ramirez-Solis, R., Liu, P., & Bradley, A. (1995) · Nature · doi:10.1038/378720a0 · Cited by 472
CHD5 Is a Tumor Suppressor at Human 1p36
Bagchi, A., Papazoglu, C., Wu, Y., Capurso, D., Brodt, M., Francis, D., Bredel, M., Vogel, H., & Mills, A. A. (2007) · Cell · doi:10.1016/j.cell.2006.11.052 · Cited by 366
Self-citationEstrogen receptors α and β in the rodent mammary gland
Saji, S., Jensen, E. V., Nilsson, S., Rylander, T., Warner, M., & Gustafsson, J.-Å. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.337 · Cited by 357
Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer
Guan, Y., Kuo, W.-L., Stilwell, J. L., Takano, H., Lapuk, A. V., Fridlyand, J., Mao, J.-H., Yu, M., Miller, M. A., Santos, J. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2882 · Cited by 347
Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer
Al-Kuraya, K., Schraml, P., Torhorst, J., Tapia, C., Zaharieva, B., Novotny, H., Spichtin, H., Maurer, R., Mirlacher, M., Köchli, O., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1945 · Cited by 347
Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
Lapointe, J., Li, C., Giacomini, C. P., Salari, K., Huang, S., Wang, P., Ferrari, M., Hernandez-Boussard, T., Brooks, J. D., & Pollack, J. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0673 · Cited by 269
Lin, M., Pedrosa, E., Shah, A., Hrabovsky, A., Maqbool, S., Zheng, D., & Lachman, H. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023356 · Cited by 242
Sato, K., Qian, J., Slezak, J. M., Lieber, M. M., Bostwick, D. G., Bergstralh, E. J., & Jenkins, R. B. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1574 · Cited by 236
Douglas, E. J., Fiegler, H., Rowan, A., Halford, S., Bicknell, D. C., Bodmer, W., Tomlinson, I. P. M., & Carter, N. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0328 · Cited by 192
Kim, Y. H., Girard, L., Giacomini, C. P., Wang, P., Hernandez-Boussard, T., Tibshirani, R., Minna, J. D., & Pollack, J. R. (2006) · Oncogene · doi:10.1038/sj.onc.1208997 · Cited by 182
Rahrmann, E. P., Watson, A. L., Keng, V. W., Choi, K., Moriarity, B. S., Beckmann, D. A., Wolf, N. K., Sarver, A. L., Collins, M. H., Moertel, C. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2641 · Cited by 169
Self-citationPhosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary Gland
Wang, X., Cunningham, M., Zhang, X., Tokarz, S., Laraway, B., Troxell, M., & Sears, R. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1032 · Cited by 165
Migration of cardiomyocytes is essential for heart regeneration in zebrafish
Itou, J., Oishi, I., Kawakami, H., Glass, T. J., Richter, J., Johnson, A., Lund, T. C., & Kawakami, Y. (2012) · Development · doi:10.1242/dev.079756 · Cited by 157
Self-citationThe 8q24 Gene Desert: An Oasis of Non-Coding Transcriptional Activity
Huppi, K. E., Pitt, J. J., Wahlberg, B. M., & Caplen, N. J. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00069 · Cited by 155
The PVT‐1 oncogene is a Myc protein target that is overexpressed in transformed cells
Carramusa, L., Contino, F., Ferro, A., Minafra, L., Perconti, G., Giallongo, A., & Feo, S. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21133 · Cited by 148
Haverty, P. M., Hon, L., Kaminker, J. S., Chant, J., & Zhang, Z. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-21 · Cited by 105
c‐myc amplification is an independent prognostic factor in postmenopausal breast cancer
Borg, Å., Baldetorp, B., Fernö, M., Olsson, H. L., & Sigurdsson, H. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510504 · Cited by 105
Jain, A. N., Chin, K., Børresen‐Dale, A., Erikstein, B., Lønning, P. E., Kaaresen, R., & Gray, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151241198 · Cited by 93
Reed, J. R., Stone, M. D., Beadnell, T. C., Ryu, Y., Griffin, T. J., & Schwertfeger, K. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045877 · Cited by 91
Self-citationBeau, M. M. L., Bitts, S. M., Davis, E. M., & Kogan, S. C. (2002) · Blood · doi:10.1182/blood.v99.8.2985 · Cited by 82
Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression
Zhang, X., Farrell, A. S., Daniel, C. J., Arnold, H., Scanlan, C., Laraway, B. J., Janghorban, M., Lum, L., Chen, D., Troxell, M. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100764108 · Cited by 81
A Critical Role for the Inflammatory Response in a Mouse Model of Preneoplastic Progression
Schwertfeger, K. L., Xian, W., Kaplan, A. M., Burnett, S. H., Cohen, D. A., & Rosen, J. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3781 · Cited by 70
Self-citationPark, K., Kwak, K., Kim, J., Lim, S., & Han, S. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.04.016 · Cited by 63
van Duin, M., van Marion, R., Vissers, K. J., Hop, W. C. J., Dinjens, W. N. M., Tilanus, H. W., Siersema, P. D., & van Dekken, H. (2007) · Cytogenetic and Genome Research · doi:10.1159/000108293 · Cited by 39
Simple and Efficient Methods for Enrichment and Isolation of Endonuclease Modified Cells
Moriarity, B. S., Rahrmann, E. P., Beckmann, D. A., Conboy, C. B., Watson, A. L., Carlson, D. F., Olson, E. R., Hyland, K. A., Fahrenkrug, S. C., McIvor, R. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096114 · Cited by 33
Self-citationLow-level copy number changes of MYC genes have a prognostic impact in medulloblastoma
Zitterbart, K., Filková, H., Tomášiková, L., Nečesalová, E., Zambo, I. S., Kantorová, D., Slámová, I., Vranová, V., Žežulková, D., Pešáková, M., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0289-3 · Cited by 27
Cited by
Gene regulation by long non-coding RNAs and its biological functions
Statello, L., Guo, C.-J., Chen, L.-L., & Huarte, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00315-9 · Cited by 4,991
Long Noncoding RNAs in Cancer Pathways
Schmitt, A. M., & Chang, H. Y. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.010 · Cited by 2,992
The emerging role of lncRNAs in cancer
Huarte, M. (2015) · Nature Medicine · doi:10.1038/nm.3981 · Cited by 2,702
Glioma Groups Based on 1p/19q,IDH, and TERT Promoter Mutations in Tumors
Eckel-Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M. L., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,982
LncRNA-mediated regulation of cell signaling in cancer
Peng, W.-X., Koirala, P., & Mo, Y.-Y. (2017) · Oncogene · doi:10.1038/onc.2017.184 · Cited by 1,661
Metadata
- Authors
- Tseng, Y.-Y., Moriarity, B. S., Gong, W., Akiyama, R., Tiwari, A., Kawakami, H., Ronning, P., Reuland, B., Guenther, K., Beadnell, T. C., Essig, J., Otto, G. M., O’Sullivan, M. G., Largaespada, D. A., Schwertfeger, K. L., Marahrens, Y., Kawakami, Y., & Bagchi, A.
- Venue
- Nature
- Published
- 2014-06-22
- Volume
- 512
- Issue
- 7512
- Pages
- 82-86
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1977572305
- Cited by
- 722
- References
- 36
- FWCI
- 17.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.